Shareholders can exchange $100 worth of the drugmaker’s stock for $108 of Zoetis stock and they can select which shares they wish to hold

By Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought...

ByCory Renauer:My last article concerning MannKind Corp. (MNKD) was a discussion of how its Afrezza will succeed where Pfizer's (PFE) Exubera failed. I still believe it can, but I didn't give MannKind's competitive landscape as much attention as I sh

CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis

CHICAGO, May 23 (Reuters) - Kathrin Jansen is amicrobiologist with at least two breakthrough vaccines to hername: she brought the cervical cancer vaccine Gardasil to marketfor Merck and helped develop the $4 billion a year pneumonia andmeningitis vac

CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis

CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine

Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfiz

CHICAGO, May 23 (Reuters) - Kathrin Jansen is amicrobiologist with at least two breakthrough vaccines to hername: she brought the cervical cancer vaccine Gardasil to marketfor Merck and helped develop the $4 billion a year pneumonia andmeningitis vac

CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis

CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis

Like any good Memorial Day sale, Pfizer sells its 80% stake in Zoetis at a 7% discount

Pfizer, Home Depot, and JPMorgan Chase are leading the way following comments from the Fed on QE3.

May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7...

May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

Pfizer plans to shed its majority stake in animal-health company Zoetis, continuing Pfizer's efforts to its hone its focus on drugs and vaccines for humans.

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.

Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.

May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7...

May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.

May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7...

Pfizer announced on Wednesday that it would shed its remaining 80 percent stake in its former animal health business, Zoetis, through an exchange offer.

NEW YORK, May 22 (Reuters) - Pfizer Inc : * Up 2.2 percent to $29.40 in premarket after plans to unwind remaining majority stake in Zoetis

May 22 (Reuters) - Pfizer Inc said on Wednesday that it would unwind its remaining stake in animal health business Zoetis Inc through an exchange offer in which shareholders can swap Pfizer stock for...

The pharmaceutical maker plans to unwind its remaining stake in the animal health business through an exchange offer.

May 22 (Reuters) - Pfizer Inc said on Wednesday that it would unwind its remaining stake in animal health business Zoetis Inc through an exchange offer in which shareholders can swap Pfizer stock for that of Zoetis at a discount.

Pfizer Inc. (NYSE: PFE) today announced its intention to split off itsremaining interest in Zoetis Inc. (NYSE: ZTS), through an exchange offer.Zoetis, formerly Pfizer's animal health business, completed its initial publicoffering (IPO) in February 20

May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it

May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it

May 20 (Reuters) - Pfizer Inc, which has been on ahot streak with three recent approvals of cancer drugs, stumbledon Monday, saying it was halting a late-stage trial of a drugfor aggressive...

Pfizer (NYSE: PFE) is trying a new sales paradigm, selling direct to patients. If this effort works, it could completely change the pharmaceutical industry.

ByCory Renauer:In case you haven't heard, pain medication abuse is getting pretty bad. In the U.S., deaths from prescription painkillers are outpacing those from heroin and cocaine combined. The FDA has noticed and is inadvertently creating new oppor

ByCory Renauer:According to the American Diabetes Association over 25 million people in the US alone have diabetes and the numbers keep on growing. Although insulin injections have come a long way, poking yourself with a needle in public still draws

By Peter Geschek:In preparation for a possible split of the company, Pfizer (PFE) is experimenting with innovative direct-to-consumer approaches.Selling Viagra directly to customers from its own website, heavy advertising on television to a mass audi

Pain Therapeutics Inc. (NASDAQ: PTIE) dipped 45.01% to $5.32 in the pre-market session after the company CEO revealed a letter from Pfizer (NYSE: PFE) of reassessing its endorsement of the Remoxy program.Santarus, Inc.

May 10 (Reuters) - Pain Therapeutics Inc said Pfizer Inc, its marketing partner for painkiller Remoxy, was yet to decide on continuing to seek regulatory approval for the drug.

May 10 (Reuters) - Pain Therapeutics Inc saidPfizer Inc, its marketing partner for painkiller Remoxy,was yet to decide on continuing to seek regulatory approval forthe drug.

SAN JUAN, Puerto Rico -- Federal authorities in Puerto Rico have arrested an executive at Pfizer Pharmaceutical for allegedly producing child pornography. Officials say 48-year-old...

By Jon Crowley:Pfizer's stock (PFE) has been on a nice run the last year despite facing a host of patent expirations. While stock repurchases and spin-offs have helped, I believe most of this growth in the stock price is because Pfizer's pipeline is

Accelrys, Inc. (NASDAQ: ACCL), aleading provider of scientific innovation lifecycle management software,announced today that Pfizer, Inc.

The drug maker will now sell its billion-dollar erectile dysfunction drug, among the world’s most counterfeited, directly to men with a doctor’s prescription.    

In a move designed to take bashfulness out of the erectile dysfunction equation, drugmaker Pfizer (NYSE: PFE) told The Associated Press that it will begin selling its popular pill, Viagra, directly to patients on

Do you want all of the ease of ordering Viagra online, with none of the risk that you’re helping support a global spam empire? Soon, you may be in luck! Sort of. Pfizer, makers of Viagra, announced recently that they plan to sell the famed erec

Blockbuster erectile dysfunction drug Viagra is about to become a lot easier for men to pick up on the down low. Pharmaceutical giant Pfizer announced Monday that it will become the first in the industry to peddle its infamous little blue pills dire

Pfizer Inc. will begin selling its popular erectile dysfunction pill Viagra to patients on its website, in an unusual move to combat counterfeit drugs.    

Pfizer announced Monday it is setting up its own site to sell Viagra online, in what it says is an effort to battle the sale of counterfeit versions of the drug.

TRENTON, N.J. (AP) — Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that...